Jpmorgan Chase & CO Inspire Medical Systems, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 399,713 shares of INSP stock, worth $33.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

399,713

Previous 519,549 23.07%

Holding current value

$33.2 Million

Previous $96.3 Million 33.9%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$157.24 - $215.42 $18.8 Million - $25.8 Million	-119,836 Reduced 23.07%	399,713 $63.7 Million
Q4 2024 Feb 12, 2025	SELL	$172.7 - $214.93 $38.4 Million - $47.8 Million	-222,369 Reduced 29.97%	519,549 $96.3 Million
Q3 2024 Dec 26, 2024	SELL	$125.79 - $216.71 $12.6 Million - $21.7 Million	-100,256 Reduced 11.9%	741,918 $157 Million
Q3 2024 Nov 08, 2024	SELL	$125.79 - $216.71 $12.6 Million - $21.7 Million	-100,256 Reduced 11.9%	741,918 $157 Million
Q2 2024 Dec 26, 2024	BUY	$133.83 - $251.19 $13.4 Million - $25.2 Million	100,256 Added 13.51%	842,174 $113 Million
Q2 2024 Aug 12, 2024	BUY	$133.83 - $251.19 $30 Million - $56.3 Million	224,024 Added 36.24%	842,174 $113 Million
Q1 2024 Dec 26, 2024	SELL	$165.3 - $226.0 $20.5 Million - $28 Million	-123,768 Reduced 16.68%	618,150 $133 Million
Q1 2024 May 10, 2024	SELL	$165.3 - $226.0 $2.27 Million - $3.1 Million	-13,731 Reduced 2.17%	618,150 $133 Million
Q4 2023 Dec 26, 2024	SELL	$125.26 - $203.83 $13.8 Million - $22.4 Million	-110,037 Reduced 14.83%	631,881 $129 Million
Q4 2023 Feb 12, 2024	BUY	$125.26 - $203.83 $66.7 Million - $109 Million	532,353 Added 534.88%	631,881 $129 Million
Q3 2023 Nov 14, 2023	SELL	$185.0 - $326.08 $10.5 Million - $18.5 Million	-56,633 Reduced 36.27%	99,528 $19.8 Million
Q2 2023 Aug 11, 2023	SELL	$226.52 - $324.64 $8.65 Million - $12.4 Million	-38,188 Reduced 19.65%	156,161 $50.7 Million
Q1 2023 May 18, 2023	BUY	$229.06 - $278.01 $8.74 Million - $10.6 Million	38,148 Added 24.42%	194,349 $45.5 Million
Q1 2023 May 11, 2023	SELL	$229.06 - $278.01 $2.03 Million - $2.47 Million	-8,869 Reduced 5.37%	156,201 $36.6 Million
Q4 2022 Feb 13, 2023	BUY	$164.02 - $259.76 $7.03 Million - $11.1 Million	42,849 Added 35.06%	165,070 $41.6 Million
Q3 2022 Nov 14, 2022	BUY	$170.68 - $226.46 $5.77 Million - $7.66 Million	33,826 Added 38.27%	122,221 $21.7 Million
Q2 2022 Aug 11, 2022	BUY	$147.53 - $266.6 $2.72 Million - $4.91 Million	18,424 Added 26.33%	88,395 $16.1 Million
Q1 2022 May 11, 2022	BUY	$193.94 - $261.91 $4.02 Million - $5.43 Million	20,719 Added 42.07%	69,971 $18 Million
Q4 2021 Feb 10, 2022	BUY	$207.57 - $280.17 $1.69 Million - $2.28 Million	8,149 Added 19.83%	49,252 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$170.0 - $258.58 $6.99 Million - $10.6 Million	41,103 New	41,103 $9.57 Million

Others Institutions Holding INSP

# of Institutions

401

Shares Held

30.1M

Call Options Held

117K

Put Options Held

148K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $2.39B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Inspire Medical Systems, Inc. Transaction History